March 19, 2025 11:09 AM EDT
Pharma

Pfiz­er ful­ly ex­its Sen­so­dyne mak­er Ha­le­on in $3.3B stake sale

Kyle LaHucik

Senior Reporter

Pfiz­er will get about $3.3 bil­lion from its fi­nal stake sale in Ha­le­on, ac­cord­ing to a Wednes­day fil­ing with the Lon­don …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

Trump pledges his sup­port for a change to the IRA long sought by drug­mak­ers

J&J's Du­a­to says 'not tar­iffs, but tax pol­i­cy' is best way to boost US man­u­fac­tur­ing

Sanofi’s Kymab-orig­i­nat­ed in­flam­ma­to­ry drug flunks mid-stage asth­ma tri­al

Phar­ma tar­iffs could leave lit­tle room to hide with sweep­ing probe un­der­way

Ex­clu­sive: A small biotech will bring Roche's An­gel­man drug back to life

sponsored

New York-based part­ner­ship sets the stan­dard for ex­pand­ing clin­i­cal tri­al ac­cess for un­der­served and di­verse ...

A service from the Financial Times